<DOC>
	<DOCNO>NCT00394446</DOCNO>
	<brief_summary>Phase 1 , Multiple Dose Study MPC-6827 Subjects Refractory Solid Tumors .</brief_summary>
	<brief_title>Phase 1 , Multiple Dose Study MPC-6827 Subjects With Refractory Solid Tumors</brief_title>
	<detailed_description />
	<criteria>1 . Advanced Metastatic Cancer 2 . Measurable / Evaluable Disease 3 . Karnofsky score great equal 70 % 4 . Adequate Hematology / Organ function 5 . No Baseline peripheral central neuropathy grade 1 1 . Hypersensitivity Cremophor EL 2 . Pregnant Lactating 3 . Spinal Cord Compression 4 . Preexisting Dementia / Cognitive Disfunction 5 . Require Neupogen Neulasta Maintain Neutrophil Count 6 . Have Primary Brain Cancer 7 . Have history Ischemic Heart Disease 8 . Have Diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Solid Tumors</keyword>
	<keyword>Refractory</keyword>
	<keyword>Brain</keyword>
</DOC>